MetLife, Inc. (NYSE:MET) Shares Sold by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. cut its stake in MetLife, Inc. (NYSE:METFree Report) by 17.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,885 shares of the financial services provider’s stock after selling 1,686 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in MetLife were worth $521,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Synovus Financial Corp raised its holdings in MetLife by 11.4% in the first quarter. Synovus Financial Corp now owns 17,847 shares of the financial services provider’s stock valued at $1,260,000 after buying an additional 1,829 shares during the period. Brighton Jones LLC purchased a new position in MetLife in the first quarter valued at approximately $225,000. Baird Financial Group Inc. raised its holdings in MetLife by 179.7% in the first quarter. Baird Financial Group Inc. now owns 540,081 shares of the financial services provider’s stock valued at $37,957,000 after buying an additional 346,999 shares during the period. Zions Bancorporation N.A. raised its holdings in MetLife by 937.3% in the first quarter. Zions Bancorporation N.A. now owns 5,861 shares of the financial services provider’s stock valued at $412,000 after buying an additional 5,296 shares during the period. Finally, Brown Brothers Harriman & Co. raised its holdings in MetLife by 114.5% in the first quarter. Brown Brothers Harriman & Co. now owns 3,419 shares of the financial services provider’s stock valued at $240,000 after buying an additional 1,825 shares during the period. 88.14% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other MetLife news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. UBS Group cut their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, February 5th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Thursday, December 7th. Wells Fargo & Company dropped their price objective on shares of MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a research note on Tuesday, February 6th. Finally, The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $77.23.

Read Our Latest Stock Analysis on MET

MetLife Stock Down 0.9 %

MET stock opened at $72.62 on Friday. MetLife, Inc. has a twelve month low of $48.95 and a twelve month high of $74.01. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $52.51 billion, a P/E ratio of 39.68, a PEG ratio of 0.55 and a beta of 1.03. The firm has a 50 day simple moving average of $69.49 and a 200-day simple moving average of $65.59.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The business had revenue of $18.72 billion during the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, equities research analysts predict that MetLife, Inc. will post 8.81 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 14th. Shareholders of record on Tuesday, February 6th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date was Monday, February 5th. MetLife’s dividend payout ratio is presently 113.66%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.